Skin Cancer Insights
Discover our latest resources like blog posts, webinars, white papers, case studies and solution briefs, with insightful information on the AI-powered device that detects skin cancer.
View our Publications with real-life success stories from physicians using the DermaSensor devices.
Better decisions, better detection, more accurate management DermaSensor empowers physicians by providing objective, actionable risk results to aid in skin cancer detection by assessing cellular and sub-cellular features that cannot be seen visually or dermoscopically. Features Indications for use The DermaSensor™ device is indicated for evaluating skin lesions suggestive of melanoma, basal cell carcinoma, and/or […]
The DermaSensor DeviceDermaSensor is a validated, FDA-cleared handheld device that non-invasively evaluates skin lesions forcancer. It captures spectral samples of a lesion and, using a proprietary algorithm, classifies the lesion’sspectral properties against those of known malignant and benign lesions. Real-World Impact: More Cancers Detected, with Greater Diagnostic EfficiencyDrs. Goisse and Thomas reviewed skin-lesion data and […]
FDA Cleared
Watch product demos, physician education, and clinical best practices to see how DermaSensor supports faster, more confident skin lesion assessment.
Catch up on expert insights, clinical best practices, and the latest innovations in skin cancer detection by watching our recorded webinars anytime.
Listen to expert conversations, clinical perspectives, and real-world insights on skin cancer detection, AI-assisted diagnostics, and patient care.
Cody Simmons discusses AI skin cancer detection on The Exceptional Average Podcast
Cody Simmons, CEO & Co-Founder of DermaSensor joins Dr. Felix Beacher.
Listen to Cody Simmons, CEO & Co-Founder of DermaSensor with Dr. Alexander Zuriarrain—renowned plastic surgeon, founder of Hydrology and Zuri Plastic Surgery in Miami, and an early adopter of DermaSensor—on the Beyond the Blade podcast.
